RSS-Feed abonnieren
DOI: 10.1055/s-2007-985609
Pulmonary Pathology of the Rheumatic Diseases
Publikationsverlauf
Publikationsdatum:
03. September 2007 (online)
ABSTRACT
Thoracic manifestations of the rheumatic diseases (RDs) are a significant cause of morbidity and mortality worldwide. The five RDs most frequently associated with pleuropulmonary disease are (1) rheumatoid arthritis (RA), (2) systemic lupus erythematosus (SLE), (3) progressive systemic sclerosis (PSS), (4) polymyositis/dermatomyositis (PM/DM), and (5) Sjögren syndrome (SS). The clinical presentation is highly variable, ranging from pleuritic pain alone to slowly progressive breathlessness accompanied by cough. On occasion RD may present acutely with overwhelming respiratory failure as the first pulmonary manifestation. In all of the RDs, the pathology is dominated by either or both inflammation and fibrosis, but the anatomical distribution in each varies somewhat. For example, airway-associated lymphoid hyperplasia is a common manifestation of SS, PM/DM preferentially involves the alveolar parenchyma, and pleural inflammation is most commonly seen in RA. Such changes may be detected radiologically as peribronchovascular disease in SS, ground-glass infiltrates in PM/DM, and pleural disease with effusion in RA. Some RDs are more commonly associated with distinctive histopathology, such as rheumatoid nodules in RA, or lymphoid hyperplasia in both RA and SS. Patients with PSS are at particular risk for pulmonary hypertension when the lung is involved. Also, statistically, acute lung injury occurs more commonly in some, such as SLE and PM/DM. The very common use of immunosuppressive agents in the treatment of RD creates additional diagnostic problems related to drug toxicity and infection. Finally, a major confounding factor occurs when preclinical RD presents first as pulmonary disease (particularly PM/DM), an occurrence that may invoke one of the so-called idiopathic interstitial pneumonias. The most common pleuropulmonary pathological manifestations of the five major RDs are presented and discussed with brief radiological correlations.
KEYWORDS
Lung - pathology - collagen vascular diseases - rheumatic
REFERENCES
- 1 Black L, Katz S. Respiratory disease: task force report on problems, research approaches, needs. 1977 DHEW Report Number NIH77-1248, National Heart and Lung Institute
- 2 Colby T V. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med. 1998; 19 587-612
- 3 Douglas W W, Tazelaar H D, Hartman T E et al.. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001; 164 1182-1185
- 4 Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999; 23 941-948
- 5 White E S, Tazelaar H D, Lynch III J P. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med. 2003; 24 543-566
- 6 Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology. 1994; 193 375-382
- 7 Yousem S, Colby T, Carrington C. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis. 1985; 131 770-777
- 8 Lamblin C, Bergoin C, Saelens T, Wallaert B. Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl. 2001; 32 69s-80s
- 9 Lee H K, Kim D S, Yoo B et al.. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005; 127 2019-2027
- 10 Yoshinouchi T, Ohtsuki Y, Fujita J et al.. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int. 2005; 26 121-125
- 11 Hakala M, Paakko P, Huhti E, Tarkka M, Sutinen S. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol. 1990; 9 452-460
- 12 Pratt D, Schwartz M, May J, Dreisen R. Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax. 1979; 34 587-593
- 13 Saag K G, Kolluri S, Koehnke R K et al.. Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996; 39 1711-1719
- 14 Kim E A, Johkoh T, Lee K S et al.. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr. 2001; 25 757-763
- 15 Cozzi F, Chiesura-Corona M, Rizzi M et al.. Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities [in Italian]. Reumatismo. 2001; 53 55-62
- 16 Desai S R, Veeraraghavan S, Hansell D M et al.. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology. 2004; 232 560-567
- 17 Bouros D, Wells A U, Nicholson A G et al.. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002; 165 1581-1586
- 18 Katzenstein A L, Fiorelli R F. Nonspecific interstitial pneumonia/fibrosis: histologic features and clinical significance. Am J Surg Pathol. 1994; 18 136-147
- 19 Fujita J, Tokuda M, Bandoh S et al.. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int. 2001; 20 81-84
- 20 Kim D S, Yoo B, Lee J S et al.. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2002; 19 121-127
- 21 Yamane K, Ihn H, Asano Y et al.. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford). 2000; 39 1269-1271
- 22 Johnson D A, Drane W E, Curran J et al.. Pulmonary disease in progressive systemic sclerosis: a complication of gastroesophageal reflux and occult aspiration?. Arch Intern Med. 1989; 149 589-593
- 23 Montesi A, Pesaresi A, Cavalli M L, Ripa G, Candela M, Gabrielli A. Oropharyngeal and esophageal function in scleroderma. Dysphagia. 1991; 6 219-223
- 24 Bridges A J, Hsu K C, Dias-Arias A A, Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol. 1992; 19 1136-1140
- 25 Muir T E, Tazelaar H D, Colby T V, Myers J L. Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc. 1997; 72 639-642
- 26 Griffin M T, Robb J D, Martin J R. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis. Thorax. 1990; 45 903-904
- 27 Bankier A A, Kiener H P, Wiesmayr M N et al.. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology. 1995; 196 835-840
- 28 Fenlon H M, Doran M, Sant S M, Breatnach E. High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol. 1996; 166 301-307
- 29 Sant S M, Doran M, Fenelon H M, Breatnach E S. Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol. 1997; 15 507-513
- 30 Ooi G C, Ngan H, Peh W C, Mok M Y, Ip M. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol. 1997; 52 775-781
- 31 Cheema G S, Quismorio Jr F P. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med. 2000; 6 424-429
- 32 Susanto I, Peters J I. Acute lupus pneumonitis with normal chest radiograph. Chest. 1997; 111 1781-1783
- 33 Gruden J F, Webb W R, Warnock M. Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation. AJR Am J Roentgenol. 1994; 162 569-574
- 34 Haupt H M, Moore G W, Hutchins G M. The lung in systemic lupus erythematosus: analysis of the pathologic changes in 120 patients. Am J Med. 1981; 71 791-798
- 35 Myers J L, Katzenstein A A. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol. 1986; 85 552-556
- 36 Fayemi A O. The lung in systemic lupus erythematosus: a clinico-pathologic study of 20 cases. Mt Sinai J Med. 1975; 42 110-118
- 37 Yokoi T, Tomita Y, Fukaya M, Ichihara S, Kakudo K, Takahashi Y. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med. 1998; 122 467-470
- 38 Roncoroni A J, Alvarez C, Molinas F. Plexogenic arteriopathy associated with pulmonary vasculitis in systemic lupus erythematosus. Respiration. 1992; 59 52-56
- 39 Wakaki K, Koizumi F, Fukase M. Vascular lesions in systemic lupus erythematosus (SLE) with pulmonary hypertension. Acta Pathol Jpn. 1984; 34 593-604
- 40 Zamora M R, Warner M L, Tuder R, Schwarz M I. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997; 76 192-202
- 41 Eisenberg H, Dubois E L, Sherwin R P, Balchum O J. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med. 1973; 79 37-45
- 42 Koh W H, Boey M L. Open lung biopsy in systemic lupus erythematosus patients with pulmonary disease. Ann Acad Med Singapore. 1993; 22 323-325
- 43 Benisch B, Peison B. The association of lymphocytic interstitial pneumonia and systemic lupus erythematosus. Mt Sinai J Med. 1979; 46 398-441
- 44 Yood R A, Steigman D M, Gill L R. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus. 1995; 4 161-163
- 45 Min J K, Hong Y S, Park S H et al.. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol. 1997; 24 2254-2257
- 46 Gammon R B, Bridges T A, al-Nezir H, Alexander C B, Kennedy Jr J I. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest. 1992; 102 1171-1174
- 47 Filipek M S, Thompson M E, Wang P L, Gosselin M V, L Primack S. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging. 2004; 19 200-203
- 48 Marenco J L, Sanchez-Burson J, Ruiz Campos J, Jimenez M D, Garcia-Bragado F. Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol. 1994; 13 525-527
- 49 Ikezoe J, Johkoh T, Kohno N, Takeuchi N, Ichikado K, Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging. 1996; 11 250-259
- 50 Tazelaar H D, Viggiano R W, Pickersgill J, Colby T V. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990; 141 727-733
- 51 Selva-O'Callaghan A, Labrador-Horrillo M, Munoz-Gall X et al.. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus. 2005; 14 534-542
- 52 Bonnefoy O, Ferretti G, Calaque O et al.. Serial chest CT findings in interstitial lung disease associated with polymyositis-dermatomyositis. Eur J Radiol. 2004; 49 235-244
- 53 Lee C S, Chen T L, Tzen C Y et al.. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol. 2002; 21 391-396
- 54 Cottin V, Thivolet-Bejui F, Reynaud-Gaubert M et al.. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J. 2003; 22 245-250
- 55 Marie I, Hachulla E, Cherin P et al.. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002; 47 614-622
- 56 Ito M, Kaise S, Suzuki S et al.. Clinico-laboratory characteristics of patients with dermatomyositis accompanied by rapidly progressive interstitial lung disease. Clin Rheumatol. 1999; 18 462-467
- 57 Fata F, Rathore R, Schiff C, Herzlich B C. Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J. 1997; 90 227-230
- 58 Hsue Y T, Paulus H E, Coulson W F. Bronchiolitis obliterans organizing pneumonia in polymyositis: a case report with long-term survival. J Rheumatol. 1993; 20 877-879
- 59 Schwarz M I, Sutarik J M, Nick J A, Leff J A, Emlen J W, Tuder R M. Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995; 151 2037-2040
- 60 Bunch T W, Tancredi R G, Lie J T. Pulmonary hypertension in polymyositis. Chest. 1981; 79 105-107
- 61 Aisa Y, Yokomori H, Kashiwagi K et al.. Polymyositis, pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection. Intern Med. 2001; 40 1109-1112
- 62 Meyer C A, Pina J S, Taillon D, Godwin J D. Inspiratory and expiratory high-resolution CT findings in a patient with Sjögren's syndrome and cystic lung disease. AJR Am J Roentgenol. 1997; 168 101-103
- 63 Franquet T, Gimenez A, Monill J M, Diaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol. 1997; 169 655-658
- 64 Hansen L A, Prakash U B, Colby T V. Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc. 1989; 64 920-931
- 65 Lohrmann C, Uhl M, Warnatz K et al.. High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome. Eur J Radiol. 2004; 52 137-143
- 66 Parambil J G, Myers J L, Lindell R M, Matteson E L, Ryu J H. Interstitial lung disease in primary Sjögren syndrome. Chest. 2006; 130 1489-1495
- 67 Ito I, Nagai S, Kitaichi M et al.. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005; 171 632-638
- 68 Jeong Y J, Lee K S, Chung M P et al.. Amyloidosis and lymphoproliferative disease in Sjögren syndrome: thin-section computed tomography findings and histopathologic comparisons. J Comput Assist Tomogr. 2004; 28 776-781
- 69 Lee I J, Kim S H, Koo S H et al.. Bronchus-associated lymphoid tissue (BALT) lymphoma of the lung showing mosaic pattern of inhomogeneous attenuation on thin-section CT: a case report. Korean J Radiol. 2000; 1 159-161
- 70 Nakamura N, Yamada G, Itoh T et al.. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren's syndrome. Intern Med. 2002; 41 309-311
- 71 Takabatake N, Sayama T, Shida K, Matsuda M, Nakamura H, Tomoike H. Lung adenocarcinoma in lymphocytic interstitial pneumonitis associated with primary Sjögren's syndrome. Respirology. 1999; 4 181-184
Kevin O LeslieM.D.
Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona
13400 E. Shea Blvd., Scottsdale, AZ 85259
eMail: leslie.kevin@mayo.edu